ArticleThe Laryngoscope2026
Effects of Ferrostatin-1 on Vocal Folds in Aging Rats.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveAge-related vocal fold degeneration is characterized by alterations in the lamina propria, extracellular matrix remodeling, and reduced tissue viscoelasticity, contributing to presbyphonia. Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, is increasingly implicated in tissue aging. This study investigated the association between ferroptosis and vocal fold aging using ferrostatin-1 (Fer-1) in a rat model.
methodsThirty-six male Sprague-Dawley rats were assigned to three groups: Young, Old, and Old-Fer. Fer-1 (2.5 μmol/kg, 20 μL) was injected unilaterally into the left vocal fold at Weeks 0 and 2. At Week 3, vocal folds were harvested for histological, immunohistochemical, and biochemical analyses. Outcome measures included ferroptosis-related markers, lamina propria thickness, extracellular matrix morphology, collagen and hyaluronic acid distribution, and inflammatory cytokines.
resultsCompared with the Young group, the Old group showed increased lipid peroxidation, reactive oxygen species, and iron accumulation with reduced glutathione peroxidase 4 activity; these changes were attenuated in the Old-Fer group. The Old group also exhibited increased lamina propria thickness, enhanced collagen deposition, and reduced hyaluronic acid distribution, whereas the Old-Fer group demonstrated reduced collagen accumulation and preserved hyaluronic acid distribution. Transforming growth factor-β and interleukin-1β expression levels were elevated in the Old group and reduced following Fer-1 treatment.
conclusionThe results indicate that ferroptosis is involved in vocal fold aging. In addition, Fer-1 effectively suppressed ferroptotic pathways, which may be associated with the attenuation of aging-related extracellular matrix alterations in the vocal folds. LEVEL OF EVIDENCE: NA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.